It was reported to boston scientific corporation on october 05, 2015 that an uncovered ultraflex esophageal ng stent was implanted during a stent placement procedure performed on (b)(6) 2015.According to the complainant, the stent was implanted to treat a 5mm benign fistula in the proximal esophagus caused by stomach cancer.Reportedly, the patient's anatomy was not tortuous and had not been dilated prior to stent placement.The stent was successfully implanted without issue.On (b)(6) 2015, during a planned stent removal, the physician attempted to remove the stent using a foreign body gripper; however, the stent retention suture broke and the stent was unable to be removed.The physician noted that the difficulty removing the stent was probably due to some noted tissue ingrowth within the stent.On (b)(6) 2015, the physician deployed a wallflex esophageal stent within the previously implanted stent, completing the procedure.There were no patient complications reported as a result of this event.The patient's condition at the conclusion of the procedure was reported to be okay.Please note, the uncovered ultraflex esophageal ng stent was not used per the directions for use (dfu).The uncovered ultraflex esophageal ng stent was used to cover a benign fistula and the ultraflex esophageal ng stent system dfu notes the stent is contraindicated for "placement for occlusion of esophageal fistula of any type, unless a covered stent is being used.".
|